1. Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Issue 13 (13th April 2022) Authors: Alvarez‐Larrán, Alberto; Garrote, Marta; Ferrer‐Marín, Francisca; Pérez‐Encinas, Manuel; Mata‐Vazquez, M. Isabel; Bellosillo, Beatriz; Arellano‐Rodrigo, Eduardo; Gómez, Montse; García, Regina; García‐Gutiérrez, Valentín; Gasior, Mercedes; Cuevas, Beatriz; Angona, Anna; Gómez‐Casares, María Teresa... Journal: Cancer Issue: Volume 128:Issue 13(2022) Page Start: 2441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗